Literature DB >> 7672516

Epitope studies indicate that histidyl-tRNA synthetase is a stimulating antigen in idiopathic myositis.

A Martin1, M J Shulman, F W Tsui.   

Abstract

The most frequently found myositis-specific antibody, the anti-Jo-1 antibody (anti-HRS), binds to histidyl-tRNA synthetase (HRS). Although this antibody reacts with HRS, it is unclear whether HRS is the stimulating antigen or is merely a protein that cross-reacts with a yet undefined antigen. Because antibody directed against an unrelated antigen would not be expected to cross-react with HRS at multiple sites, we mapped the epitopes on HRS to resolve this issue. We found by Western blot analyses that immunoglobulins G (IgG) from 18 of 19 anti-HRS positive patient sera react with amino acids 2-44 and 286-509 of HRS. Patient IgG specific for these two epitopes were found not to inhibit HRS enzyme activity. Instead, the inhibitory property of anti-HRS was found to be associated with antibodies that do not react to HRS in immunoblots, indicating the presence of other epitopes. In addition, antibodies that react in immunoblots were found to represent only a small fraction of total anti-HRS antibody. Our finding that patient IgG recognized at least three distinct epitopes on HRS strongly suggests that the immunological response at some point in the disease is directed against HRS and not against a cross-reactive antigen.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7672516     DOI: 10.1096/fasebj.9.12.7672516

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  10 in total

Review 1.  Role of Jo-1 in the Immunopathogenesis of the Anti-synthetase Syndrome.

Authors:  Dana P Ascherman
Journal:  Curr Rheumatol Rep       Date:  2015-09       Impact factor: 4.592

2.  Role of innate immunity in a murine model of histidyl-transfer RNA synthetase (Jo-1)-mediated myositis.

Authors:  Makoto Soejima; Eun Ha Kang; Xinyan Gu; Yasuhiro Katsumata; Paula R Clemens; Dana P Ascherman
Journal:  Arthritis Rheum       Date:  2011-02

Review 3.  Myositis-specific autoantibodies: detection and clinical associations.

Authors:  Sander H J van Dooren; Walther J van Venrooij; Ger J M Pruijn
Journal:  Auto Immun Highlights       Date:  2011-03-23

4.  Utility of paraneoplastic antigens as biomarkers for surveillance and prediction of recurrence in ovarian cancer.

Authors:  Madhumita Chatterjee; Laura C Hurley; Nancy K Levin; Matthew Stack; Michael A Tainsky
Journal:  Cancer Biomark       Date:  2017-12-06       Impact factor: 4.388

5.  Species-specific immune responses generated by histidyl-tRNA synthetase immunization are associated with muscle and lung inflammation.

Authors:  Yasuhiro Katsumata; William M Ridgway; Timothy Oriss; Xinyan Gu; David Chin; Yuehong Wu; Noreen Fertig; Tim Oury; Daniel Vandersteen; Paula Clemens; Carlos J Camacho; Andrew Weinberg; Dana P Ascherman
Journal:  J Autoimmun       Date:  2007 Sep-Nov       Impact factor: 7.094

Review 6.  The role of Jo-1 in the immunopathogenesis of polymyositis: current hypotheses.

Authors:  Dana P Ascherman
Journal:  Curr Rheumatol Rep       Date:  2003-12       Impact factor: 4.592

7.  Secreted histidyl-tRNA synthetase splice variants elaborate major epitopes for autoantibodies in inflammatory myositis.

Authors:  Jie J Zhou; Feng Wang; Zhiwen Xu; Wing-Sze Lo; Ching-Fun Lau; Kyle P Chiang; Leslie A Nangle; Melissa A Ashlock; John D Mendlein; Xiang-Lei Yang; Mingjie Zhang; Paul Schimmel
Journal:  J Biol Chem       Date:  2014-06-04       Impact factor: 5.157

8.  Internally deleted human tRNA synthetase suggests evolutionary pressure for repurposing.

Authors:  Zhiwen Xu; Zhiyi Wei; Jie J Zhou; Fei Ye; Wing-Sze Lo; Feng Wang; Ching-Fun Lau; Jingjing Wu; Leslie A Nangle; Kyle P Chiang; Xiang-Lei Yang; Mingjie Zhang; Paul Schimmel
Journal:  Structure       Date:  2012-09-05       Impact factor: 5.006

9.  Jo-1 autoantigen-specific B cells are skewed towards distinct functional B cell subsets in anti-synthetase syndrome patients.

Authors:  Jennifer Young-Glazer; Alberto Cisneros; Erin M Wilfong; Scott A Smith; Leslie J Crofford; Rachel H Bonami
Journal:  Arthritis Res Ther       Date:  2021-01-19       Impact factor: 5.606

Review 10.  Developments in the scientific and clinical understanding of inflammatory myopathies.

Authors:  Ingrid E Lundberg; Cecilia Grundtman
Journal:  Arthritis Res Ther       Date:  2008-10-10       Impact factor: 5.156

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.